These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8748048)

  • 21. Selective serotonin reuptake inhibitor and akathisia.
    Poyurovsky M; Weizman A
    J Clin Psychopharmacol; 1997 Dec; 17(6):489. PubMed ID: 9408813
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
    Hieber R; Dellenbaugh T; Nelson LA
    Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
    Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
    Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine and ECT combination therapy.
    Farah A
    Convuls Ther; 1997 Jun; 13(2):116-7. PubMed ID: 9253533
    [No Abstract]   [Full Text] [Related]  

  • 25. [Salivation test in patients with affective disorders treated with amitriptyline, mianserin and electroconvulsive therapy].
    Hese RT
    Psychiatr Pol; 1992; 26(1-2):29-36. PubMed ID: 1298001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychotic symptoms as a complication of electroconvulsive therapy - a case report.
    Antosik-Wójcińska A; Chojnacka M; Święcicki Ł
    Psychiatr Pol; 2017 Feb; 51(1):23-27. PubMed ID: 28455892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electroconvulsion therapy for neuroleptic malignant syndrome].
    Buggenhout S; Vandenberghe J; Sienaert P
    Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies of adverse effects in patients with refractory depression treated with amitryptyline, mianserin and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2001; 35(2):219-29. PubMed ID: 11490887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akathisia associated with mianserin.
    Aggarwal A; Khandelwal A; Garg A; Jiloha RC
    J Clin Psychopharmacol; 2010 Jun; 30(3):338-9. PubMed ID: 20473077
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mianserin pharmacokinetics and behavior in hyperkinetic children.
    Winsberg BG; Camp-Bruno JA; Vink J; Timmer CJ; Sverd J
    J Clin Psychopharmacol; 1987 Jun; 7(3):143-7. PubMed ID: 3597800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electroconvulsive therapy: 80 years of use in psychiatry].
    Kaliora SC; Zervas IM; Papadimitriou GN
    Psychiatriki; 2018; 29(4):291-302. PubMed ID: 30814039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotic effect of electroconvulsive therapy is related to normalization of subgenual cingulate theta activity in psychotic depression.
    McCormick LM; Yamada T; Yeh M; Brumm MC; Thatcher RW
    J Psychiatr Res; 2009 Feb; 43(5):553-60. PubMed ID: 18851858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Episodic Visual Learning/Memory and Attentional Flexibility in Patients With Major Depressive Disorder After Clinically Effective Electroconvulsive Therapy.
    Kalogerakou S; Oulis P; Anyfandi E; Konstantakopoulos G; Papakosta VM; Kontis D; Theochari E; Angelopoulos E; Zervas IM; Mellon RC; Papageorgiou CC; Tsaltas E
    J ECT; 2015 Dec; 31(4):246-52. PubMed ID: 25973768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECT and non-memory cognition: a review.
    Calev A; Gaudino EA; Squires NK; Zervas IM; Fink M
    Br J Clin Psychol; 1995 Nov; 34(4):505-15. PubMed ID: 8563658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bitemporal Versus High-Dose Unilateral Twice-Weekly Electroconvulsive Therapy for Depression (EFFECT-Dep): A Pragmatic, Randomized, Non-Inferiority Trial.
    Semkovska M; Landau S; Dunne R; Kolshus E; Kavanagh A; Jelovac A; Noone M; Carton M; Lambe S; McHugh C; McLoughlin DM
    Am J Psychiatry; 2016 Apr; 173(4):408-17. PubMed ID: 26892939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroconvulsive therapy use in a 97-year-old woman.
    Burke D; Shannon J; Beveridge A
    Australas Psychiatry; 2007 Oct; 15(5):427-30. PubMed ID: 17828642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.